NM_147127.5:c.2095A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_147127.5(EVC2):​c.2095A>G​(p.Thr699Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.318 in 1,613,758 control chromosomes in the GnomAD database, including 94,610 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T699M) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.45 ( 18957 hom., cov: 32)
Exomes 𝑓: 0.31 ( 75653 hom. )

Consequence

EVC2
NM_147127.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 1.54

Publications

34 publications found
Variant links:
Genes affected
EVC2 (HGNC:19747): (EvC ciliary complex subunit 2) This gene encodes a protein that functions in bone formation and skeletal development. Mutations in this gene, as well as in a neighboring gene that lies in a head-to-head configuration, cause Ellis-van Creveld syndrome, an autosomal recessive skeletal dysplasia that is also known as chondroectodermal dysplasia. Mutations in this gene also cause acrofacial dysostosis Weyers type, also referred to as Curry-Hall syndrome, a disease that combines limb and facial abnormalities. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
EVC2 Gene-Disease associations (from GenCC):
  • acrofacial dysostosis, Weyers type
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P
  • Ellis-van Creveld syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, Myriad Women's Health, Laboratory for Molecular Medicine

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_147127.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=1.0240383E-6).
BP6
Variant 4-5622943-T-C is Benign according to our data. Variant chr4-5622943-T-C is described in ClinVar as Benign. ClinVar VariationId is 262610.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.781 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_147127.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
NM_147127.5
MANE Select
c.2095A>Gp.Thr699Ala
missense
Exon 14 of 22NP_667338.3
EVC2
NM_001166136.2
c.1855A>Gp.Thr619Ala
missense
Exon 14 of 22NP_001159608.1Q86UK5-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EVC2
ENST00000344408.10
TSL:1 MANE Select
c.2095A>Gp.Thr699Ala
missense
Exon 14 of 22ENSP00000342144.5Q86UK5-1
EVC2
ENST00000310917.6
TSL:1
c.1855A>Gp.Thr619Ala
missense
Exon 14 of 22ENSP00000311683.2Q86UK5-2
EVC2
ENST00000475313.5
TSL:1
n.1855A>G
non_coding_transcript_exon
Exon 14 of 23ENSP00000431981.1A0A0C4DGE7

Frequencies

GnomAD3 genomes
AF:
0.447
AC:
67848
AN:
151906
Hom.:
18912
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.788
Gnomad AMI
AF:
0.248
Gnomad AMR
AF:
0.408
Gnomad ASJ
AF:
0.265
Gnomad EAS
AF:
0.610
Gnomad SAS
AF:
0.299
Gnomad FIN
AF:
0.351
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.275
Gnomad OTH
AF:
0.394
GnomAD2 exomes
AF:
0.366
AC:
91740
AN:
250438
AF XY:
0.351
show subpopulations
Gnomad AFR exome
AF:
0.798
Gnomad AMR exome
AF:
0.423
Gnomad ASJ exome
AF:
0.261
Gnomad EAS exome
AF:
0.633
Gnomad FIN exome
AF:
0.342
Gnomad NFE exome
AF:
0.281
Gnomad OTH exome
AF:
0.325
GnomAD4 exome
AF:
0.305
AC:
445835
AN:
1461732
Hom.:
75653
Cov.:
66
AF XY:
0.303
AC XY:
219983
AN XY:
727156
show subpopulations
African (AFR)
AF:
0.807
AC:
27026
AN:
33476
American (AMR)
AF:
0.419
AC:
18754
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.264
AC:
6912
AN:
26136
East Asian (EAS)
AF:
0.609
AC:
24170
AN:
39698
South Asian (SAS)
AF:
0.285
AC:
24550
AN:
86250
European-Finnish (FIN)
AF:
0.339
AC:
18084
AN:
53372
Middle Eastern (MID)
AF:
0.321
AC:
1853
AN:
5764
European-Non Finnish (NFE)
AF:
0.274
AC:
304628
AN:
1111930
Other (OTH)
AF:
0.329
AC:
19858
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
19812
39624
59435
79247
99059
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10526
21052
31578
42104
52630
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.447
AC:
67942
AN:
152026
Hom.:
18957
Cov.:
32
AF XY:
0.450
AC XY:
33415
AN XY:
74300
show subpopulations
African (AFR)
AF:
0.788
AC:
32685
AN:
41486
American (AMR)
AF:
0.408
AC:
6228
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.265
AC:
921
AN:
3470
East Asian (EAS)
AF:
0.610
AC:
3149
AN:
5160
South Asian (SAS)
AF:
0.300
AC:
1445
AN:
4820
European-Finnish (FIN)
AF:
0.351
AC:
3704
AN:
10562
Middle Eastern (MID)
AF:
0.279
AC:
82
AN:
294
European-Non Finnish (NFE)
AF:
0.275
AC:
18681
AN:
67944
Other (OTH)
AF:
0.389
AC:
821
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1566
3131
4697
6262
7828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
572
1144
1716
2288
2860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.336
Hom.:
34770
Bravo
AF:
0.472
Asia WGS
AF:
0.478
AC:
1661
AN:
3478
EpiCase
AF:
0.274
EpiControl
AF:
0.283

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Ellis-van Creveld syndrome (1)
-
-
1
Ellis-van Creveld syndrome;C0457013:Curry-Hall syndrome (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.65
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
5.3
DANN
Benign
0.15
DEOGEN2
Benign
0.033
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.26
T
MetaRNN
Benign
0.0000010
T
MetaSVM
Benign
-0.96
T
MutationAssessor
Benign
-1.1
N
PhyloP100
1.5
PrimateAI
Benign
0.36
T
PROVEAN
Benign
0.070
N
REVEL
Benign
0.16
Sift
Benign
1.0
T
Sift4G
Benign
1.0
T
Varity_R
0.022
gMVP
0.039
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs730469;
hg19: chr4-5624670;
COSMIC: COSV60389754;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.